HungaroTrial is proud to be able to offer the following services for the active research of possible COVID -19 therapies.:
- HungaroTrial provides Regulatory Fast Track for COVID-019 trials in Hungary and Romania
- Due to the fast track application sites can be initiated within ONE MONTH of the contract signature with us
- Our experienced clinical team is able to conduct remote and on-site visits using a variety of systems due to our extensive partnership experience
- We can provide a certified Infectologist MD to assist with your studies including Medical Monitoring
Benefits of the CEE region are:
- Fast Track Applications for COVID-19 Studies
- High enrollment rate
- Cost effective trials
- Centralized healthcare
- Experienced and Motivated Investigators
We are proud to show that we have already started assisting in the fight with COVID-19 having submitted a Phase III application under the COVID-019 fast track application which received approval in 4 days.
Our Clinical Team is excited to be part of active research of possible COVID-19 therapies.